MEDVi vs Embody
Side-by-side comparison of MEDVi ($179–$299) and Embody ($149 first month / $299 flat refills). Pricing, medications, features, pros, and cons in one view.
MEDVi
Reliable mid-tier compounded GLP-1
- Highest brand-search volume in our verified stack (27K reviews/mo)
- Mid-tier pricing — competitive entry point
- 30-day consult flexibility — no long-term commitment
- Live catalog blocked from crawler (loading-splash SPA)
- No branded GLP-1 (Wegovy/Zepbound) options
Embody
Flat $299/mo refills + GLP-1 gum (needle-free)
- Highest realized EPC ($4.60) and conversion rate (1.31%) in our active stack — Katalys-verified
- Flat $299/mo refills — no escalation fees as dose increases
- GLP-1 gum is a unique oral-format differentiator (only provider in stack)
- Compounded only — no branded GLP-1 (Wegovy/Zepbound)
- Lab work not included in base price
- Sermorelin not offered in core GLP-1 program
Which Should You Pick?
MEDVi has the strongest brand-search signal of any provider in the stack. Live product catalog requires manual screenshot — but pricing range is Gronk-verified. Strong candidate for "Best Brand Recognition" badge.
The data leader in the Katalys-approved stack: $4.60 EPC and 1.31% conversion rate beat every other GLP-1 program we track. The flat $299/mo refill price (no dose-escalation upcharges) is genuinely uncommon in compounded telehealth, and the GLP-1 gum is a real differentiator for needle-averse patients.
Both verdicts above reflect the editorial summary on each provider’s detail page. For your specific situation, take the match quiz.
Still deciding?
Our 60-second quiz matches you to the right provider based on insurance, medication preference, and budget.
Take the Quiz